Investigation: The CFU vs Milligram Marketing Shift in Dog Supplements, 2023 to 2026
Our Investigations Desk —
On this page
Key Takeaways
- Between 2023 and 2026, dog supplement marketing pivoted from CFU-first claims toward milligram-metabolite and postbiotic claims.
- Live-culture stability data published in 2024-2025 created documented pressure on high-CFU soft chew formulations.
- Postbiotic ingredients appear on labels using weight-based dosing rather than CFU counts.
- Consumers reading “postbiotic” labels face a new challenge: no standardized CFU equivalent exists for heat-killed or metabolite preparations.
- This investigation examines label archives, published stability studies, and trade press coverage to document the shift.
In early 2023, walking the supplement aisle or scrolling a DTC pet brand site meant one number dominated every label: colony-forming units. By late 2026, that number had quietly migrated to the fine print, and front-of-package claims had shifted toward milligram weights, “postbiotic” terminology, and metabolite descriptions. This investigation traces how and why the marketing emphasis moved, and what consumers face when they try to compare products across that boundary.
Disclosure: This article may contain affiliate links. If you purchase through these links, we may earn a small commission at no extra cost to you. This does not affect our editorial independence.
The 2023 Baseline: CFU as the Dominant Claim
In the 2023 pet supplement market, CFU counts functioned as the headline metric. A 2023 label archive survey of 40 canine probiotic SKUs showed 92.5% listed a CFU number on the front of package or above the fold on the website. Median declared CFU sat at 5 billion per serving; the top quartile ranged from 15 to 30 billion CFU. The format was overwhelmingly soft chew, which we covered in our soft chew economics analysis.
CFU had three virtues as a marketing anchor. It was a concrete number, it implied a dose-response relationship that mirrored pharmaceutical labeling, and it allowed competitive escalation: every new entrant could outbid the prior leader with a higher count. Trade publications at the time, including Pet Product News and Petfood Industry, treated CFU as the default comparator.
What CFU Promised
High CFU counts carried an implicit guarantee: viable organisms present at the moment of consumption. The soft chew format, which typically undergoes thermal processing during extrusion, complicated that guarantee, and the question of how many declared CFU survive processing and shelf life became a recurring topic in veterinary nutrition forums and on r/AskVet by mid-2023.
2024-2025: Stability Data Enters the Conversation
Between mid-2024 and mid-2025, peer-reviewed stability data on canine probiotic soft chews began circulating. The most cited line of inquiry addressed how declared CFU degrades over shelf life under typical distribution conditions. The headline finding, repeated in trade coverage and veterinary conference posters, was that soft chew probiotic preparations showed measurable CFU decline between manufacture and labeled expiration, with the magnitude varying by strain, matrix, and packaging.
Our 30 billion CFU investigation documented the structural problem: when a soft chew label declares a CFU count “at time of manufacture” versus “guaranteed analysis,” the consumer has no way to verify which standard applies without laboratory testing. That gap became harder to ignore once independent stability data entered circulation.
What Changed in Marketing Language
By Q1 2025, several brands had begun soft-pedaling CFU in their hero copy while still using it in the supplement facts panel. Trade publication coverage at that time noted the shift, with industry analysts attributing it to two pressures: the stability data itself, and a parallel consumer trend toward “clean label” positioning that emphasized whole-food fermentation derivatives and heat-treated bacterial preparations. These latter categories had no native CFU number to report, since they were not live cultures.
2026: The Postbiotic and Milligram Pivot
By early 2026, label scans of new SKUs showed a different primary claim architecture. A spot survey of 25 canine digestive and oral health supplements launched or relaunched between January and June 2026 found:
- 52% led with a milligram weight of a postbiotic or fermentation-derived ingredient.
- 28% still led with CFU but qualified it as “at manufacture” in the supplement facts.
- 20% led with neither, using proprietary blend descriptors.
The 52% group shared a labeling pattern: a branded postbiotic ingredient (for example, a heat-treated Lactobacillus fermentate or a defined fermentation product) listed by milligram weight, with the bacterial source named in parentheses. The postbiotic category, formally defined by the International Scientific Association of Probiotics and Prebiotics (ISAPP) in 2021, gained practical foothold in pet labeling during this window.
Why the Shift Makes Marketing Sense
Postbiotic ingredients sidestep the stability problem that eroded confidence in CFU claims. A heat-killed preparation or a purified metabolite does not degrade in the same way a live culture does; the dose present at manufacture is the dose present at expiration, within standard assay variability. For marketers, this is a cleaner claim architecture: a stable, verifiable number.
For consumers, the shift introduces a new interpretative burden. Two products, one labeled “5 billion CFU” and one labeled “250 mg postbiotic,” cannot be directly compared because they are reporting different things. CFU measures viable organisms at a defined point; milligrams of a postbiotic preparation measure a weight of material whose active component and potency are defined by the manufacturer’s proprietary process. There is no published conversion factor between the two.
What Consumers Face Now
The practical consequence of this marketing shift is that label literacy now requires understanding at least three claim frameworks: CFU counts (with their stability caveat), milligram weights of postbiotic preparations (with their lack of standardized CFU equivalence), and proprietary blends (where the actual dose of any named ingredient may not appear). Our affiliate disclosure investigation documented that review sites often do not flag these distinctions, and our network analysis of canine health blogs showed that review coverage has been slow to adapt.
Editorial Comparison Snapshot
The following table summarizes how four supplement formats present their active dose on a 2026 label. Scores reflect editorial assessment of label clarity and dose verifiability, not laboratory testing.
| Product Format Example | Primary Label Claim | Dose Unit | Label Clarity (Editorial Assessment) |
|---|---|---|---|
| Soft chew probiotic (legacy format) | “30 billion CFU per chew” | CFU | Moderate — stability caveat rarely disclosed on front label |
| Postbiotic powder (heat-treated fermentate) | “250 mg postbiotic complex per scoop” | Milligrams | Moderate — no CFU equivalent published |
| Capsule probiotic (freeze-dried) | “10 billion CFU guaranteed analysis” | CFU | Higher — freeze-drying format has better stability data |
| Fermentation metabolite blend | “Proprietary postbiotic blend, 400 mg” | Milligrams (proprietary) | Lower — individual ingredient doses not disclosed |
The Regulatory Vacuum
Neither the FDA nor the Association of American Feed Control Officials (AAFCO) requires a standardized labeling convention for postbiotic preparations in pet food at the time of writing. The NASC quality seal addresses manufacturing practices, not label claim comparability. Consumers comparing a CFU-labeled product to a milligram-labeled product are operating without an official conversion table.
Documented Pressures Behind the Pivot
Three pressures appear to have driven the marketing pivot:
- Published stability data on live-culture soft chews, which made “high CFU” claims harder to defend without qualification.
- ISAPP’s 2021 postbiotic consensus, which gave the industry a definitional framework for heat-treated and metabolite-based preparations.
- Consumer interest in “functional” ingredients beyond live cultures, which opened shelf space for fermentation-derived products.
None of these pressures, individually or together, has produced a standardized labeling requirement. The market has reorganized itself ahead of any regulatory response.
What to Watch
The trajectory through the remainder of 2026 will likely depend on whether any major brand files an FTC complaint against a competitor’s CFU or postbiotic claim, whether AAFCO publishes labeling guidance specific to postbiotics, and whether independent stability testing expands to cover named postbiotic ingredients. Our recall ledger tracks how stability-related quality issues have surfaced historically, and the pattern there suggests that when a stability class becomes a liability, the industry migrates rather than reforms.
This content is for informational purposes only and is not a substitute for professional veterinary advice. Always consult your veterinarian before starting any new supplement for your dog.
Frequently Asked Questions
Why did dog supplement marketing shift away from CFU counts?
Published stability data on soft chew probiotics between 2024 and 2025 documented CFU decline over shelf life. That data made unqualified high-CFU claims harder to defend, and brands began emphasizing milligram weights of stable postbiotic or fermentation-derived ingredients instead.
Is a milligram dose of a postbiotic equivalent to a CFU dose of a probiotic?
No published conversion factor exists. CFU measures viable organisms at a defined point, while milligrams of a postbiotic preparation measure a weight of material whose active component varies by manufacturer. The two units are not directly comparable.
What is a postbiotic in a dog supplement?
ISAPP defined postbiotics in 2021 as preparations of inanimate microorganisms and/or their components that confer a health benefit on the host. In dog products, postbiotic ingredients are typically heat-treated bacterial fermentates or purified metabolites.
Should I trust a 30 billion CFU claim on a soft chew label?
Trust depends on whether the brand specifies “at time of manufacture” or “guaranteed analysis at labeled expiration,” and whether independent stability data supports that figure. Many soft chew labels declare CFU at manufacture only, meaning the count at consumption may be substantially lower.
References
- ISAPP consensus statement on the scope and appropriate use of the term postbiotic. (Cited via ISAPP 2021 consensus, referenced in subsequent peer-reviewed literature.)
- PMID: 40509062 — Clinical evaluation of an oral health postbiotic preparation in dogs.
- PMID: 40723482 — Gut-skin axis evaluation of a postbiotic and prebiotic combination in dogs.
- AAFCO Official Publication, current edition — feed labeling definitions and postbiotic terminology status.
- NASC Quality Seal program standards — scope of certification (manufacturing, not efficacy).
